TopFunds

Quest Diagnostics

NYSE: DGX

Stock price

246.48 USD

(+59.26%) 5 years

Health Care ServicesMedical - Diagnostics & Research

Insider Transactions

5Y price score: 81
Help

The price score is a basic measure of the stock's performance against the S&P 500 Index over a five-year period.

A score of 100 indicates that the stock did as well as the S&P 500 Index.

A score below 100 means the stock underperformed the index, while a score above 100 means it outperformed the S&P 500.

5Y return: +59.26%
DATE RANGE:
USD PER SHARE

  • Stock price
  • Sales
  • Purchases
  • Stock awards

Transaction History

Trade log
DateActionSharesPriceShare ValueHoldingNameTitleSource
01-sep.-26Sale(10,000)242.7(2,427,200)122,423Davis J. E.director, officer: CEO and Presidentlink
28-aug.-26Sale(16,010)242.9(3,888,437)44,224PREVOZNIK MICHAEL Eofficer: SVP & General Counsellink
28-aug.-26Sale(6,237)243.6(1,519,505)37,987PREVOZNIK MICHAEL Eofficer: SVP & General Counsellink
28-aug.-26Sale(430)244.5(105,141)37,557PREVOZNIK MICHAEL Eofficer: SVP & General Counsellink
28-jul.-26Sale(1,600)235.2(376,288)10,335DELANEY MARK Eofficer: SVP & Chief Commercial Officerlink
22-jul.-26Award72206.814,89018,386Gregg Vicky Bdirectorlink
22-jul.-26Award102206.821,09433,478SAMAD SAMofficer: Executive Vice President & CFOlink
01-jul.-26Award144--342WENTWORTH TIMOTHY Cdirectorlink
04-jun.-26Sale(8,147)200.0(1,629,400)13,510KUPPUSAMY KARTHIKofficer: SVP, Clinical Solutionslink
01-jun.-26Sale(10,000)194.1(1,941,400)132,423Davis J. E.director, officer: CEO and Presidentlink

171.1

52-week range

248.7

246.48

Your model inputs

Required return / cost of capital
%
FCFF terminal growth rate
%

Your fair value & Margin of safety

To calculate fair value based on cost of capital and terminal growth assumptions above, please select free cash flow forecast.

Forecast:

Set price notification

Valuation

Free Cash Flow Yield

Help
FCF Yield TTM = Trailing Twelve Months free cash flow per share / current market price per shareLearn more

4.4 %

Dividend Yield TTM

1.3 %

Market cap $

$ 27,205

Price / Earnings TTM

Help
P/E TTM = current market price per share / Trailing Twelve Months diluted earnings per shareLearn more

26.2

Price / Book TTM

3.6

PEG TTM

Help
Price/Earnings-to-Growth ratio = P/E TTM divided by most recent annual diluted earnings per share growth rateLearn more

1.9

Earnings growth and return

LTM

5YR

10YR

Total return (price & dividends)

36.2 %

68.7 %

225.2 %

Free cash flow per share growth

(23.6) %

3.1 %

218.8 %

Earnings per share growth

15 %

(16.8) %

79.7 %

Dividends

Previous dividend:0.86 per share, Paid, Ex-div date Jul 08, 2026
Next dividend:0.86 per share, Declared, Ex-div date Oct 06, 2026

Analyst ratings

Price Target Low

225

Price Target High

260

Price Target Median

247.5

Buy

13

Hold

18

Sell

3

Financials

all figures in USD Millions except per share data

Periods:

View:

Forecast:

Help

Averages

based on historical growth rates (CAGR) and average margins for last 10 or max, available and up to 10 years.

Analysts

Average Revenue and Net Income forecast estimates from analysts who cover the stock.

Custom

you can edit default forecast based on averages or analysts consensus and use it to calculate fair value based on your assumptions.

ㅤ

Actual
10 year gagr
Estimated
Projected
Fiscal
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Average (A)
2026
2027
2028
2029
2030
Terminal
FISCAL PERIOD END DATES
SHOW FORECAST VS ACTUAL
01Earnings per share
Help
Diluted EPSLearn more
4.9
4.5
5.5
5.3
6.3
10.5
15.5
8
7.5
7.7
8.8
6%
11.3
12
12.8
13.7
14.5
15.4
02FCF per share
3.8
5.5
6.6
5.9
6.2
11.7
14.3
11.1
7.6
8
12
12.3%
11.5
12.1
12.7
13.3
14
14.5
03Dividends per share
Help
Adjusted for splitsLearn more
1.5
1.6
1.8
2
2.1
2.2
2.4
3.3
2.8
3
3.2
7.9%
-
-
-
-
-
-
04Dividends payout, %
29.9%
34.6%
32%
36.1%
33.3%
20.8%
15.5%
32.2%
36.8%
38%
35.6%
1.8%
-
-
-
-
-
-
05Revenue
$ 7,493
$ 7,515
$ 7,709
$ 7,531
$ 7,726
$ 9,437
$ 10,788
$ 9,883
$ 9,252
$ 9,872
$ 11,035
4%
$ 11,471
$ 11,923
$ 12,394
$ 12,883
$ 13,392
$ 13,793
06ㅤ% Change
-
0.3%
2.6%
(2.3)%
2.6%
22.2%
14.3%
(8.4)%
(6.4)%
6.7%
11.8%
4%
4%
4%
4%
4%
4%
4%
07Net Income
709
645
772
736
858
1,431
1,995
946
854
871
992
3.4%
1,243
1,292
1,343
1,396
1,451
1,495
08ㅤ% Margin
9.5%
8.6%
10%
9.8%
11.1%
15.2%
18.5%
9.6%
9.2%
8.8%
9%
10.8% A
10.8%
10.8%
10.8%
10.8%
10.8%
10.8%
09CFO
810
1,069
1,175
1,200
1,243
2,005
2,233
1,718
1,272
1,334
1,886
8.8%
1,835
1,908
1,983
2,061
2,142
2,207
10ㅤ% Of revenue
10.8%
14.2%
15.2%
15.9%
16.1%
21.3%
20.7%
17.4%
13.8%
13.5%
17.1%
16% A
16%
16%
16%
16%
16%
16%
11CAPEX
(263)
(293)
(252)
(383)
(400)
(418)
(403)
(404)
(408)
(425)
(527)
7.2%
(564.9)
(605.6)
(649.2)
(695.9)
(746)
(799.7)
12ㅤ% Change
-
11.4%
(14)%
52%
4.4%
4.5%
(3.6)%
0.3%
1%
4.2%
24%
7.2% A
7.2%
7.2%
7.2%
7.2%
7.2%
7.2%
13FCFF
Help
Free Cash Flow to the Firm = Cash Flows from Operating Activities (09) – Capital Expenditures (11)Learn more
547
776
923
817
843
1,587
1,830
1,314
864
909
1,359
9.5%
1,270
1,302
1,334
1,365
1,396
1,407
14Total assets
9,962
10,100
10,503
11,003
12,843
14,026
13,611
12,837
14,022
16,153
16,225
5%
17,036
17,888
18,782
19,721
20,706
21,741
15ㅤ% Change
-
1.4%
4%
4.8%
16.7%
9.2%
(3)%
(5.7)%
9.2%
15.2%
0.5%
5%
5%
5%
5%
5%
5%
5%
16Total liabilities
5,179
5,363
5,468
5,659
7,080
7,135
7,049
6,830
7,604
9,257
8,939
5.6%
9,386
9,855
10,348
10,865
11,408
11,978
17ㅤ% Of assets
52%
53.1%
52.1%
51.4%
55.1%
50.9%
51.8%
53.2%
54.2%
57.3%
55.1%
55.1% A
55.1%
55.1%
55.1%
55.1%
55.1%
55.1%
18Shareholders Equity
4,783
4,737
5,035
5,344
5,763
6,891
6,562
6,007
6,418
6,896
7,286
4.3%
7,650
8,033
8,434
8,856
9,298
9,763
19Net Debt
3,518
3,375
3,718
3,856
4,224
3,650
3,901
4,399
4,812
6,538
6,499
6.3%
-
-
-
-
-
-
20Shares Outstanding
Help
Diluted Weighted-average Shares OutstandingLearn more
145,000
142,000
140,000
139,000
136,000
136,000
128,000
118,000
113,000
113,000
113,000
(2.5)%
110,217
107,503
104,856
102,273
99,755
97,298
21ㅤ% Change
-
(2.1)%
(1.4)%
(0.7)%
(2.2)%
-
(5.9)%
(7.8)%
(4.2)%
-
-
(2.5)%
(2.5)%
(2.5)%
(2.5)%
(2.5)%
(2.5)%
(2.5)%
22ROA
7.1%
6.4%
7.4%
6.7%
6.7%
10.2%
14.7%
7.4%
6.1%
5.4%
6.1%
-
7.3%
7.2%
7.2%
7.1%
7%
6.9%
23ROE
14.8%
13.6%
15.3%
13.8%
14.9%
20.8%
30.4%
15.8%
13.3%
12.6%
13.6%
-
16.3%
16.1%
15.9%
15.8%
15.6%
15.3%
24Interest coverage
9.1
8.9
7.6
6.5
6.8
11.9
15.7
9.6
7.7
6
5.8
-
-
-
-
-
-
-
25Dividend Yield
2.1%
1.7%
1.8%
2.4%
2%
1.9%
1.4%
1.7%
2%
2%
1.8%
-
-
-
-
-
-
-
26P/E Ratio
14.5
20.1
17.5
15.4
16.7
11.2
10.9
19.3
18.2
19.3
19.6
-
-
-
-
-
-
-
27Stock price range
61-80
61-93
91-111
80-115
81-108
73-130
115-173
122-164
121-156
124-164
150-192
-
-
-
-
-
-
-
28Market Cap
Help
End of Period Market CapLearn more
10,244
12,866
13,493
11,325
14,310
15,969
21,626
18,147
15,443
16,746
19,262
6.5%
11,130
12,881
14,807
16,926
19,257
-
29FCF Yield
5.3%
6%
6.8%
7.2%
5.9%
9.9%
8.5%
7.2%
5.6%
5.4%
7.1%
2.8%
11.4%
10.1%
9%
8.1%
7.3%
-
30Average stock price
70.1
76.6
100.9
97.4
94.3
101.7
143.8
143.1
138.2
143.8
171.3
9.4%
101
119.8
141.2
165.5
193
-
31 CEO
JD
James E. Davis